{"id":316783,"date":"2026-10-19T14:28:11","date_gmt":"2026-10-19T08:58:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316783"},"modified":"2026-10-19T14:28:11","modified_gmt":"2026-10-19T08:58:11","slug":"antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/","title":{"rendered":"3 Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks With a Strong Future Roadmap: Concord Biotech, FDC and AWL Agri Business"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Concord Biotech Rs 1,339.00, P\/E 51.00. FDC Rs 356.25, P\/E 18.05. AWL Agri Rs 187.30, P\/E 20.49. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Antibiotic ingredient, oral rehydration and edible oil stocks with the clearest long-term roadmaps today include Concord Biotech in fermentation-based active ingredients, including immunosuppressants and anti-infectives, FDC in oral rehydration products such as Electral along with eye, ear and anti-infective formulations and AWL Agri in edible oils, packaged foods and staples sold under the Fortune brand. P\/E stands at 51.00 for Concord Biotech (industry 37.59), 18.05 for FDC (industry 37.59) and 20.49 for AWL Agri (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Antibiotic ingredient, oral rehydration and edible oil stocks give investors exposure to drug ingredients, everyday health products and kitchen staples. Volumes, pricing and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three antibiotic ingredient, oral rehydration and edible oil stocks: Concord Biotech for fermentation-based active ingredients, including immunosuppressants and anti-infectives, FDC for oral rehydration products such as Electral along with eye, ear and anti-infective formulations and AWL Agri Business for edible oils, packaged foods and staples sold under the Fortune brand. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#What_Are_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\" title=\"What Are Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks?\">What Are Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_at_a_Glance\" title=\"Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks at a Glance\">Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Why_Do_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks Have a Strong Roadmap in India?\">Why Do Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Concord_Biotech_Fermentation_Ingredients_Drive_the_Pipeline\" title=\"Concord Biotech: Fermentation Ingredients Drive the Pipeline\">Concord Biotech: Fermentation Ingredients Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#FDC_Established_Brands_Drive_the_Pipeline\" title=\"FDC: Established Brands Drive the Pipeline\">FDC: Established Brands Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#AWL_Agri_Business_Edible_Oils_and_Staples_Build_the_Next_Leg\" title=\"AWL Agri Business: Edible Oils and Staples Build the Next Leg\">AWL Agri Business: Edible Oils and Staples Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Best_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_in_India_Concord_Biotech_vs_FDC_vs_AWL_Agri_on_Key_Financials\" title=\"Best Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks in India: Concord Biotech vs FDC vs AWL Agri on Key Financials\">Best Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks in India: Concord Biotech vs FDC vs AWL Agri on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#How_to_Evaluate_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks to Buy Before You Invest\">How to Evaluate Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Risks_to_Consider_Before_Investing_in_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\" title=\"Risks to Consider Before Investing in Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks\">Risks to Consider Before Investing in Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#FAQs_on_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\" title=\"FAQs on Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks\">FAQs on Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Which_are_the_best_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best antibiotic ingredient, oral rehydration and edible oil stocks in India with a strong roadmap?\">Which are the best antibiotic ingredient, oral rehydration and edible oil stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Is_Concord_Biotech_a_good_stock_to_buy_now\" title=\"Is Concord Biotech a good stock to buy now?\">Is Concord Biotech a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#What_is_the_PE_ratio_of_Concord_Biotech_FDC_and_AWL_Agri\" title=\"What is the P\/E ratio of Concord Biotech, FDC and AWL Agri?\">What is the P\/E ratio of Concord Biotech, FDC and AWL Agri?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Which_of_these_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_has_the_highest_return_on_equity\" title=\"Which of these antibiotic ingredient, oral rehydration and edible oil stocks has the highest return on equity?\">Which of these antibiotic ingredient, oral rehydration and edible oil stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#What_are_the_risks_of_investing_in_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks\" title=\"What are the risks of investing in antibiotic ingredient, oral rehydration and edible oil stocks?\">What are the risks of investing in antibiotic ingredient, oral rehydration and edible oil stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#How_did_Concord_Biotech_FDC_and_AWL_Agri_perform_in_Q1_FY27\" title=\"How did Concord Biotech, FDC and AWL Agri perform in Q1 FY27?\">How did Concord Biotech, FDC and AWL Agri perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#Do_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_pay_dividends\" title=\"Do antibiotic ingredient, oral rehydration and edible oil stocks pay dividends?\">Do antibiotic ingredient, oral rehydration and edible oil stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-roadmap-anchor-list\/#How_can_I_invest_in_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_in_India\" title=\"How can I invest in antibiotic ingredient, oral rehydration and edible oil stocks in India?\">How can I invest in antibiotic ingredient, oral rehydration and edible oil stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\"><\/span><strong>What Are Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Antibiotic ingredient, oral rehydration and edible oil stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_at_a_Glance\"><\/span><strong>Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three antibiotic ingredient, oral rehydration and edible oil stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\">Concord Biotech<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,339.00<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13,913<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">51.00<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.94%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/fdc\/fdc-ltd-share-price-today\">FDC<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">356.25<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,281<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.32%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/awl\/adani-wilmar-ltd-share-price-today\">AWL Agri Business<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">187.30<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23,732<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.49<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare and consumer stocks, Concord Biotech trades at a premium to the industry P\/E, while FDC and AWL Agri trade at a discount.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Antibiotic ingredient, oral rehydration and edible oil stocks have a strong roadmap in India because drug ingredient demand, everyday health products and household food spending keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Ingredient demand:<\/strong> Drug makers buy fermentation-based ingredients.<\/li>\n<li><strong>Everyday health:<\/strong> Families buy rehydration and eye and ear care products.<\/li>\n<li><strong>Kitchen staples:<\/strong> Families buy edible oils and packaged foods.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Concord_Biotech_Fermentation_Ingredients_Drive_the_Pipeline\"><\/span><strong>Concord Biotech: Fermentation Ingredients Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Concord Biotech&#8217;s roadmap rests on fermentation-based active ingredients, including immunosuppressants and anti-infectives, with regulated market exports supporting revenue.<\/p>\n<p>Revenue grew from Rs 736.35 crore in FY22 to Rs 1,107.25 crore in FY26, a 50.4% rise. FY26 net profit was Rs 259.23 crore. In Q1 FY27, revenue grew 24.2% to Rs 270.32 crore, and net profit rose 31.0% to Rs 57.70 crore. Operating margin was 39.81% in FY26.<\/p>\n<p>Debt to equity is 0.00 and return on equity is 12.94%. FY26 operating cash flow was Rs 266.88 crore against capital expenditure of Rs 95.15 crore. Concord Biotech paid a dividend of Rs 7.55 per share for FY26, a yield of 0.57%. At a P\/E of 51.00 against an industry P\/E of 37.59, the stock trades above its industry multiple.<\/p>\n<p>What to watch: The P\/E of 51.00 sits above the industry P\/E of 37.59, so earnings delivery matters for the valuation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FDC_Established_Brands_Drive_the_Pipeline\"><\/span><strong>FDC: Established Brands Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>FDC&#8217;s roadmap rests on oral rehydration products such as Electral along with eye, ear and anti-infective formulations, with established brands supporting steady sales.<\/p>\n<p>Revenue grew from Rs 1,604.01 crore in FY22 to Rs 2,284.45 crore in FY26, a 42.4% rise, and FY26 revenue was 3.9% higher than FY25. FY26 net profit rose 5.5% to Rs 281.42 crore. Over four years, net profit rose from Rs 216.16 crore in FY22 to Rs 281.42 crore. In Q1 FY27, revenue grew 4.6% to Rs 715.35 crore, and net profit rose 9.2% to Rs 132.49 crore. Operating margin was 20.21% in FY26 and 28.56% in Q1 FY27 against 27.12% a year earlier.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 11.32%. FY26 operating cash flow was Rs 200.45 crore against capital expenditure of Rs 186.56 crore. FDC paid a dividend of Rs 5 per share for FY26, a yield of 1.54%. At a P\/E of 18.05 against an industry P\/E of 37.59, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 28.56% against 20.21% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"AWL_Agri_Business_Edible_Oils_and_Staples_Build_the_Next_Leg\"><\/span><strong>AWL Agri Business: Edible Oils and Staples Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>AWL Agri&#8217;s roadmap rests on edible oils, packaged foods and staples sold under the Fortune brand, with a wide distribution network supporting volumes.<\/p>\n<p>Revenue grew from Rs 54,327.16 crore in FY22 to Rs 75,148.47 crore in FY26, a 38.3% rise, and FY26 revenue was 17.6% higher than FY25. FY26 net profit was Rs 990.44 crore. In Q1 FY27, revenue grew 16.5% to Rs 20,116.91 crore, and net profit rose 47.7% to Rs 351.39 crore. Operating margin was 3.38% in FY26 and 3.90% in Q1 FY27 against 3.39% a year earlier.<\/p>\n<p>Debt to equity is 0.11 and return on equity is 9.98%. FY26 operating cash flow was Rs 3,928.34 crore against capital expenditure of Rs 833.37 crore. AWL Agri paid a dividend of Rs 1 per share for FY26, a yield of 0.55%. At a P\/E of 20.49 against an industry P\/E of 34.85, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Net profit margin is only 1.3%, so small cost changes move earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_in_India_Concord_Biotech_vs_FDC_vs_AWL_Agri_on_Key_Financials\"><\/span><strong>Best Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks in India: Concord Biotech vs FDC vs AWL Agri on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best antibiotic ingredient, oral rehydration and edible oil stocks in India, Concord Biotech leads on FY26 operating margin and Q1 FY27 revenue growth; FDC leads on the lowest P\/E and dividend yield; AWL Agri leads on Q1 FY27 net profit growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Concord Biotech<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FDC<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">AWL Agri<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,107.25<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,284.45<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">75,148.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">259.23<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">281.42<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">990.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">39.81%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.21%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.38%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 net profit growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">47.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.94%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.32%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">51.00<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.49<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.57%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.54%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">266.88<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">200.45<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,928.34<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen antibiotic ingredient, oral rehydration and edible oil stocks and shortlist antibiotic ingredient, oral rehydration and edible oil stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these antibiotic ingredient, oral rehydration and edible oil stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\"><\/span><strong>Risks to Consider Before Investing in Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Concord Biotech, FDC and AWL Agri live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare and consumer stocks cover drug ingredients, rehydration products and kitchen staples. Concord Biotech leads on FY26 operating margin and Q1 FY27 revenue growth; FDC leads on the lowest P\/E and dividend yield; AWL Agri leads on Q1 FY27 net profit growth.<\/p>\n<p>Across antibiotic ingredient, oral rehydration and edible oil stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the antibiotic ingredient, oral rehydration and edible oil stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Antibiotic_Ingredient_Oral_Rehydration_and_Edible_Oil_Stocks\"><\/span><strong>FAQs on Antibiotic Ingredient, Oral Rehydration and Edible Oil Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best antibiotic ingredient, oral rehydration and edible oil stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech, FDC and AWL Agri Business stand out for their roadmaps in drug ingredients, rehydration products and kitchen staples. Return on equity ranges from 9.98% to 12.94%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Concord_Biotech_a_good_stock_to_buy_now\"><\/span><strong>Is Concord Biotech a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech has a debt to equity ratio of 0.00, a return on equity of 12.94% and a P\/E of 51.00 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Concord_Biotech_FDC_and_AWL_Agri\"><\/span><strong>What is the P\/E ratio of Concord Biotech, FDC and AWL Agri?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 51.00 for Concord Biotech (industry 37.59), 18.05 for FDC (industry 37.59) and 20.49 for AWL Agri (industry 34.85). Only Concord Biotech trades at or above the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these antibiotic ingredient, oral rehydration and edible oil stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech has the highest return on equity at 12.94%, followed by FDC at 11.32% and AWL Agri Business at 9.98%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks\"><\/span><strong>What are the risks of investing in antibiotic ingredient, oral rehydration and edible oil stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Concord_Biotech_FDC_and_AWL_Agri_perform_in_Q1_FY27\"><\/span><strong>How did Concord Biotech, FDC and AWL Agri perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech reported revenue of Rs 270.32 crore, up 24.2% year on year, and net profit rose 31.0% to Rs 57.70 crore. FDC reported revenue of Rs 715.35 crore, up 4.6% year on year, and net profit rose 9.2% to Rs 132.49 crore. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_pay_dividends\"><\/span><strong>Do antibiotic ingredient, oral rehydration and edible oil stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.57% for Concord Biotech, 1.54% for FDC and 0.55% for AWL Agri, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_antibiotic_ingredient_oral_rehydration_and_edible_oil_stocks_in_India\"><\/span><strong>How can I invest in antibiotic ingredient, oral rehydration and edible oil stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy antibiotic ingredient, oral rehydration and edible oil stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best antibiotic ingredient, oral rehydration and edible oil stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Concord Biotech, FDC and AWL Agri Business stand out for their roadmaps in drug ingredients, rehydration products and kitchen staples. Return on equity ranges from 9.98% to 12.94%.\"}},{\"@type\":\"Question\",\"name\":\"Is Concord Biotech a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Concord Biotech has a debt to equity ratio of 0.00, a return on equity of 12.94% and a P\/E of 51.00 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Concord Biotech, FDC and AWL Agri?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 51.00 for Concord Biotech (industry 37.59), 18.05 for FDC (industry 37.59) and 20.49 for AWL Agri (industry 34.85). Only Concord Biotech trades at or above the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these antibiotic ingredient, oral rehydration and edible oil stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Concord Biotech has the highest return on equity at 12.94%, followed by FDC at 11.32% and AWL Agri Business at 9.98%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in antibiotic ingredient, oral rehydration and edible oil stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.\"}},{\"@type\":\"Question\",\"name\":\"How did Concord Biotech, FDC and AWL Agri perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Concord Biotech reported revenue of Rs 270.32 crore, up 24.2% year on year, and net profit rose 31.0% to Rs 57.70 crore. FDC reported revenue of Rs 715.35 crore, up 4.6% year on year, and net profit rose 9.2% to Rs 132.49 crore. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do antibiotic ingredient, oral rehydration and edible oil stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.57% for Concord Biotech, 1.54% for FDC and 0.55% for AWL Agri, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in antibiotic ingredient, oral rehydration and edible oil stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy antibiotic ingredient, oral rehydration and edible oil stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Concord Biotech, FDC and AWL Agri Business compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":34,"featured_media":316782,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13374,11210,11240,11207,13375,13376],"class_list":["post-316783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-antibiotic-ingredient","tag-awl-agri-business","tag-concord-biotech","tag-fdc","tag-oral-rehydration-and-edible-oil-stocks","tag-oral-rehydration-and-edible-oil-stocks-to-buy"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["316782"],"rank_math_title":["drug ingredient, rehydration and edible oil stocks"],"rank_math_description":["Antibiotic ingredient, oral rehydration and edible oil stocks with a strong roadmap: Concord Biotech, FDC and AWL Agri compared on growth, valuation and risks."],"rank_math_focus_keyword":["antibiotic ingredient, oral rehydration and edible oil stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-antibiotic-ingredient-oral-rehydration-and-edible-oil-stocks-with-a-strong.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=316783"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316783\/revisions"}],"predecessor-version":[{"id":316784,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316783\/revisions\/316784"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/316782"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=316783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=316783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=316783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}